Sugi Predict

Sugi Predict / Compounds / SCHEMBL6007355

SCHEMBL6007355

SCHEMBL6007355

CON=C(N)c1ccc(Br)cc1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.58
▸ RAB9A P51151 9/20 0.58
▸ ATM Q13315 2/20 0.58
▸ POLB P06746 1/20 0.57
▸ GSK3B P49841 1/20 0.56
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ LMNA P02545 3/20 0.51
▸ CYP1A2 P05177 1/20 0.50
▸ HPGD P15428 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974042 0.83 NPC1 (0.42) NPC1RAB9AATMPOLBSMN1; SMN2
SCHEMBL13882951 0.81 SMN1; SMN2 (0.54) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL14902858 0.81 SMN1; SMN2 (0.54) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL6650000 0.81 MASP2 (0.43) NPC1RAB9AATMPOLBSMN1; SMN2
SCHEMBL4722865 0.78 NPC1 (0.54) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL4722868 0.78 NPC1 (0.54) NPC1RAB9APOLBSMN1; SMN2MAPT
SCHEMBL23901725 0.78 L3MBTL1 (0.49) NPC1RAB9AATMPOLBSMN1; SMN2
SCHEMBL14578296 0.77 GSK3B (0.58) NPC1RAB9AATMGSK3BSMN1; SMN2
SCHEMBL27825259 0.77 GSK3B (0.58) NPC1RAB9AATMGSK3BSMN1; SMN2
SCHEMBL20880149 0.76 SMN1; SMN2 (0.52) NPC1RAB9AATMSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565457-A2 PROCESS FOR SYNTHESIS BIS-ARYL DIAMIDOXIME COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-08-24 — — EP claimed
US-20040127721-A1 Process for the synthesis of bis-aryl diamidoxime compounds UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2004-07-01 — — US claimed
WO-2004051217-A2 PROCESS FOR SYNTHESIS BIS-ARYL DIAMIDOXIME COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2004-06-17 — — WO claimed
US-7071338-B2 such as 2,5-bis[4-hydroxy and 4-O-alkylamidinophenyl]furan compounds, from amidoxime compounds with 2,5-bis-tri-alkylstannannes via one step palladium-catalyzed cross reaction THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2006-07-04 — — US disclosed
EP-1565457-A2 PROCESS FOR SYNTHESIS BIS-ARYL DIAMIDOXIME COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2005-08-24 — — EP disclosed
US-20040127721-A1 Process for the synthesis of bis-aryl diamidoxime compounds UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2004-07-01 — — US disclosed
WO-2004051217-A2 PROCESS FOR SYNTHESIS BIS-ARYL DIAMIDOXIME COMPOUNDS UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2004-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127721-A1 Process for the synthesis of bis-aryl diamidoxime compounds DDT, DAO, DDO NPC1 4838/4885RAB9A 2902/4885ATM 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.